The next multibillion-dollar therapeutic area for drug companies may be fatty liver disease, but there are a few practical hurdles to overcome first
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
ICYMI: Arizona buys back state capitol, misses big opportunity for realtor showOn the latest episode of Capitol Gains, Governor Doug Doocey's looking for an open concept state capitol with 123,000 square feet and plenty of space for political parties on a budget of $1 billion.
Baca lebih lajut »
The Exchange: Big Weed's big yearListen: Bruce Linton runs the world's biggest cannabis producer, Canopy Growth. He visited Breakingviews to discuss what's coming down the pipe in 2019, why a $100 bln weed company is still some way off, and why he doesn't actually partake - yet.
Baca lebih lajut »
Ford's CEO says a 'big surprise' is coming next year with electric vehicles'We have 16 models that are in design and development. We have a pretty big surprise coming next year,' Ford CEO Jim Hackett told CNBC.
Baca lebih lajut »
Apple’s Next Big Move? It Should Buy NintendoApple won’t rule out a big acquisition, but never mind those flashy names like Tesla and Netflix. Japan’s Nintendo offers the perfect match.
Baca lebih lajut »
After the Smartphone: The Race for the Next Big ThingVenture-capital investors are spraying money into fields like virtual reality, driverless cars and even implants in the brain.
Baca lebih lajut »
Would Big Pharma Pay for the Wall?Ensuring the federal government reopens soon is very much in the pharmaceutical industry’s interest. Absent a deal, the FDA will run out of funds to process applications for new drugs.
Baca lebih lajut »